Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Clinical Trials are both science and an important idea. On 20 Oct the Department of Oncology took its place in the main chamber of the Oxford Town Hall as part of the IF Oxford Science and Ideas Festival 2019.

Our stall set out a short and colourful introduction to some key ideas in how to design a clinical trial in Oncology.

By comparing the results of treating a number of plastic figures we were able to understand the importance of testing any new idea against the gold standard of care. We were also able to understand the importance of personalised medicine and the consequences of not taking the variable nature of cancer into account.

We met lots of very enthusiastic people.

 

 

If you would like to know more about IF, please visit their website -  https://if-oxford.com/about/

Similar stories

Glowing dye helps surgeons eradicate prostate cancer

A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study led by the University of Oxford.

Festive Science Image Competition Winners

Winners of the Medical Research Foundation's second Festive Science Image Competition, run in partnership with the Medical Research Council (MRC), have been announced today.

The Howat Foundation to fund Chair in Clinical Oncology

Oxford Cancer announce the endowment of a Chair in Clinical Oncology, thanks to generous philanthropic support from The Howat Foundation

Scientists find genetic ‘marker’ linked to serious side-effects from skin cancer treatment

New research from the Fairfax Group has identified a genetic marker that could be used to predict a patient’s risk of developing serious side-effects when undergoing immunotherapy treatment for metastatic melanoma.

MP Anneliese Dodds tours Oxford cancer research

Anneliese Dodds, MP for Oxford East & Chair of the Labour Party, visited the University of Oxford to learn more about the impactful work happening across departments in the field of cancer research.